Medical Robotics News

RSS

Hyperfine Announces FDA Clearance and Launch of Upgraded AI-Powered Swoop Software

Hyperfine, Inc., the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable magnetic resonance imaging (MRI) device for imaging of the brain, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and launch of the company’s upgraded AI-powered software.

14 Feb 2023

AI-Powered Z-Smart Massage Chair Plus Transforms the Physical Healthcare World

Zarifa USA announced the AI technology in their massage chairs has revolutionized the physical healthcare world. With the help of AI algorithms, the chairs can detect the muscle tension of each individual and adjust the massage intensity accordingly. Zarifa USA CEO Yama Mustafawi made the announcement.

13 Feb 2023

AI Determines the Consequences of Twisting Arteries

Around 119 areas present in the genome, which aid in identifying the shape and size of the blood vessels at the back of the eye, have been discovered through a study headed by researchers at St George’s, University of London.

10 Feb 2023

MetiStream and Carilion Clinic Join Hands to Identify High-Risk Colon Cancer Patients Using AI-Enabled Ember Platform

MetiStream Incorporated, a leader in transforming unstructured health data into usable clinical insights, is expanding its relationship with Carilion Clinic, a Roanoke, VA-headquartered healthcare system, to identify high-risk colon cancer patients using MetiStream's Artificial Intelligence (AI) enabled Ember Platform.

9 Feb 2023

ClosedLoop Named Best in KLAS for Healthcare Artificial Intelligence: Data Science Solutions for the Second Time

ClosedLoop, healthcare's data science platform, today announced that it has been named Best in KLAS for Healthcare Artificial Intelligence: Data Science Solutions for the second year in a row.

9 Feb 2023

Absci Expands Scientific Advisory Board to Continue to Pioneer AI Drug Creation

Absci Corporation, a generative AI drug creation company, today announced the expansion of its Scientific Advisory Board with three world-class scientific leaders: Victor Greiff, Ph.D., Timothy Lu, MD, Ph.D., and Hubert Truebel, MD, Ph.D., MBA.

9 Feb 2023

Generative AI Discovered and Designed Drug for Idiopathic Pulmonary Fibrosis Gets FDA Orphan Drug Designation

Insilico Medicine, a clinical-stage end-to-end generative artificial intelligence (AI)-driven drug discovery company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to INS018_055 for the treatment of Idiopathic Pulmonary Fibrosis (IPF).

9 Feb 2023

AI to Predict the Success of Chemotherapy in Breast Cancer

At the University of Waterloo, engineers have come up with artificial intelligence (AI) technology to forecast if women with breast cancer would benefit from chemotherapy before surgery.

8 Feb 2023

Syneos Health Collaborates with Haystack Health to Improve Clinical Trials with AI

Syneos Health®, the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with Haystack Health, a Roivant Health portfolio company developing advanced Artificial Intelligence (AI) and Natural Language Processing (NLP) solutions, to improve the identification and enrollment of patients for clinical trials.

8 Feb 2023

New Test Uses AI to Accurately Identify Respiratory Viruses Within Five Minutes

Collaboration with John Radcliffe Hospital used AI to identify respiratory viruses and different strains with an accuracy of >97% in under five minutes.

8 Feb 2023